Correlation of preoperative thallium spect with histological grading and overall survival in adult gliomas

Nuclear Medicine Communications

Volumn 27, Issue 2, 2006, Pages 137-142

  Comte, Frédéric ^a   Bauchet, Luc ^b   Rigau, Valérie ^b   Hauet, Jean Robert ^b   Fabbro, Michel ^b   Coubes, Philippe ^b   Chevalier, Jeanine ^b   Mariano Goulart, Denis ^b   Rossi, Michel ^b   Zanca, Michel ^b  

^a Service de Neurochirurgie   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Glioma; Prognosis; SPECT; Survival; Thallium

Indexed keywords

CARMUSTINE; CISPLATIN; TEMOZOLOMIDE; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ADULT; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; GLIOMA; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN TUMOR; EVALUATION; FRANCE; INCIDENCE; METHODOLOGY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL; SURVIVAL RATE;

BRAIN NEOPLASMS; FRANCE; GLIOMA; INCIDENCE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33645230604     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000191855.19327.af     Document Type: Article

References (31)

1. Mountz JM, Raymond PA, McKeever PE, Modell JG, Hood TW, Barthel LK, Stafford-Schuck HA. Specific localization of thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989; 49:4053-4056.
2. Gungor F, Bezircioglu H, Guvenc G, Tezcan M, Yildiz A, Uluc E, Isisag A. Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours. Nucl Med Commun 2000; 21:803-810.
3. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connoly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987; 28:47-52.
4. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71:342-346.
5. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe H, Tateno M, et al. Clinical evaluation of thallium-201 SPECT in supratentorial relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34:2085-2089.
6. Slizofski WJ, Krishna L, Katsetos CD, Black P, Miyamoto C, Brown Vender J, et al. Thallium imaging for brain tumors with results measured by semiquantitative index and correlated with histopathology. Cancer 1994; 74:3190-3197.
7. Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, et al. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 1998; 89:60-68.
8. Higa T, Maetani S, Yoichiro K, Nabeshima S. Tl-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas. Clin Nucl Med 2001; 26:119-124.
9. Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single photon emission computed tomography. Semin Nucl Med 2003; 33:148-162.
10. Vertosick FT Jr., Selker RG, Grossman SL, Joyce JM. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurg 1994; 34:396-401.
11. Kosuda S, Fujii H, Aoski S, Suzuki K, Tanaka Y, Nakamura O, et al. Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiot Oncol Biol Phys 1994; 30:1201-1206.
12. Vos MJ, Hoekstra OS, Berkhof F, Heimans JJ, van Groenigen CJ, et al. Thallium-201 single photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol 2003; 21:3559-3565.
13. Cipri S, Mannino R, Ruggieri R, Gambardella G. Clinical evaluation of thallium-201 single photon emission computed tomography in equivocal neuroradiological supratentorial lesions. J Neurosurg Sci 2001; 45:75-82.
14. 201Tl SPECT in the differential diagnosis of brain tumours. Nucl Med Commun 1999; 20: 637-645.
15. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 1993; 4:257-263.
16. Hemm S, Vayssiere N, Zanca M, Ravel P, Coubes P. Thallium SPECT-based stereotactic targeting for brain tumor biopsies. A technical note. Sterotact Funct Neurosurg 2004; 82:70-76.
17. 201Tl-SPECT and MRI applied to brain tumor biopsies. J Nucl Med 2005; 46:(in press).
18. Martinez del Valle M, Gomez-Rio M, Horcajadas A, Rodriguez-Fernandex A, Muros de Fuentes A, Acosta-Gomez MJ, et al. False positive thallium-201 SPECT imaging in brain abscess. Br J Radiol 2000; 73:160-164.
19. Lam W, Chan K, Wong W, Poon W, Metreweli C. Pre-operative grading of intracranial glioma. Comparison of MR-determined cerebral blood volume maps with thallium-201 SPECT. Acta Radiol 2001; 42:548-554.
20. Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990; 41:965-969.
21. Burkard R, Kaiser KP, Wieler H, Klawki P, Linkamp A, Mittlebach L, Goller T. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain. Neurosurg Rev 1992; 15:265-273.
22. Kallen K, Heiling M, Andersson AM, Brun A, Holtas S, Ryding E. Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. Am J Neuroradiol 1996; 17:925-932.
23. 123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas. Eur J Nucl Med 2001; 28:273-281.
24. Matheja P, Rickert C, Weckesser M, Palkovic S, Lottgen J, Riemann B, et al. Sequential scintigraphic strategy for the differentiation of brain tumours. Eur J Nucl Med 2000; 27:550-558.
25. 201Tl SPECT and CT in the follow-up of irradiated brain tumors. Int J Clin Oncol 2004; 9:51-58.
26. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999; 22:210-214.
27. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001; 95:746-750.
28. 11C] methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000; 27:542-549.
29. 18F]fluoroethyl)-L-tyrosine PET for the diagnostic of recurrent glioma. Eur J Nucl Med Mol Imaging 2004; 31:1464-1470.
30. 123I]iodo-α-methyl-L-tyrosine SPECT in brain tumors. J Nucl Med 2004; 45:374-381.
31. 18F]fluoroethyl)-L-tyrosine PET combined with MRI in the diagnostic assessment of cerebral gliomas. Brain 2005; 128:678-687.